2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

Drug derivatives are derived from parent compounds. They replace or add atoms and groups through chemical reactions to optimize the various properties of the parent compound and reduce side effects. The application of drug derivatives provides a diverse compound library for drug research and development and accelerates the discovery of new drugs. For example, urea derivatives Glibenclamide can prolong the blood sugar-lowering effect of anti-diabetic drugs.

Drug Derivative Related Products (1533):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-125080
    BIBS-222
    BIBS-222 is an active compound.
    BIBS-222
  • HY-W267932
    WAY-271999
    		98.0%
    WAY-271999 is an active molecule.
    WAY-271999
  • HY-164507
    NRMA-7
    NRMA-7 is a BBB-penetrable small molecule nuclear receptor modulator. NRMA-7 can be used in the study of central nervous system diseases.
    NRMA-7
  • HY-49072
    WAY-620473
    		98.0%
    WAY-620473 is an active molecule.
    WAY-620473
  • HY-116081
    LY 221501
    LY 221501 is an active compound.
    LY 221501
  • HY-105035
    Rodorubicin
    Rodorubicin (Cytorhodin S) is a tetraglycosidic anthracycline with preclinical antitumor activity.
    Rodorubicin
  • HY-128470
    Mitoquidone
    Mitoquidone (GR-30921) is is the first member of a group of pentacyclic pyrroloquinones. Mitoquidone shows good activity in a range of experimental solid tumour models. Mitoquidone can be used for the research of anti-cancer.
    Mitoquidone
  • HY-148153
    C6-Amide-(PEG)n-CH3
    C6-Amide-(PEG)n-CH3 (n=310) is an active compound. C6-Amide-(PEG)n-CH3 is a small molecule moiety for PEGylation in Egaptivon pegol (HY-147079) that can be used for the research of platelet dysfunction disorders.
    C6-Amide-(PEG)n-CH3
  • HY-133059
    MRZ-8676
    MRZ-8676 is an active compound.
    MRZ-8676
  • HY-117077
    A70450
    A70450 is an active compound.
    A70450
  • HY-167847
    IRI-514
    IRI-514 is a synthetic peptide analogue of Thymopentin (HY-N7122). IRI-514 plays a role in modulating behavioral and neuroendocrine responses to stress.
    IRI-514
  • HY-N7557
    (E)-2'-Hydroxy-3,4-dimethoxychalcone
    (E)-2'-Hydroxy-3,4-dimethoxychalcone (compound 7) is a Chalcone derivative with orally active. (E)-2'-Hydroxy-3,4-dimethoxychalcone has anti-tumour activities.
    (E)-2'-Hydroxy-3,4-dimethoxychalcone
  • HY-121776
    Nicomol
    		98.40%
    Nicomol is an orally active hypolipidemic agent that can increase the high density lipoprotein cholesterol (HDL-C) level. Nicomol inhibits the rapid rise of plasma free fatty acids.
    Nicomol
  • HY-113733
    ICI-195739
    ICI-195739 is an active compound.
    ICI-195739
  • HY-113743
    Ecomustine
    Ecomustine (CY233) is a nitrosoureido sugar derived from acosamine. Ecomustine shows antitumour activity.
    Ecomustine
  • HY-118248
    HW 173
    HW 173 is an active compound.
    HW 173
  • HY-120219
    TU-2100
    TU-2100 is an active compound.
    TU-2100
  • HY-19239
    FP-21399
    FP-21399 is an active compound.
    FP-21399
  • HY-113716
    Adecypenol
    Adecypenol is an active compound.
    Adecypenol
  • HY-119268
    Thiosildenafil
    Thiosildenafil, a Sildenafil (HY-15025) analogue, is a compound found in health supplement.
    Thiosildenafil